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Objective: Estimating calibration performance of clinical prediction rules (CPRs) in system-
atic reviews of validation studies is not possible when predicted values are neither published 
nor accessible or sufficient or no individual participant or patient data are available. Our aims 
were to describe a simplified approach for outcomes prediction and calibration assessment and 
evaluate its functionality and validity.
Study design and methods: Methodological study of systematic reviews of validation stud-
ies of CPRs: a) ABCD2 rule for prediction of 7 day stroke; and b) CRB-65 rule for prediction 
of 30 day mortality. Predicted outcomes in a sample validation study were computed by CPR 
distribution patterns (“derivation model”). As confirmation, a logistic regression model (with 
derivation study coefficients) was applied to CPR-based dummy variables in the validation 
study. Meta-analysis of validation studies provided pooled estimates of “predicted:observed” 
risk ratios (RRs), 95% confidence intervals (CIs), and indexes of heterogeneity (I2) on forest 
plots (fixed and random effects models), with and without adjustment of intercepts. The above 
approach was also applied to the CRB-65 rule.
Results: Our simplified method, applied to ABCD2 rule in three risk strata (low, 0–3; intermedi-
ate, 4–5; high, 6–7 points), indicated that predictions are identical to those computed by univari-
ate, CPR-based logistic regression model. Discrimination was good (c-statistics =0.61–0.82), 
however, calibration in some studies was low. In such cases with miscalibration, the under-
prediction (RRs =0.73–0.91, 95% CIs 0.41–1.48) could be further corrected by intercept adjust-
ment to account for incidence differences. An improvement of both heterogeneities and P-values 
(Hosmer-Lemeshow goodness-of-fit test) was observed. Better calibration and improved pooled 
RRs (0.90–1.06), with narrower 95% CIs (0.57–1.41) were achieved.
Conclusion: Our results have an immediate clinical implication in situations when predicted 
outcomes in CPR validation studies are lacking or deficient by describing how such predictions 
can be obtained by everyone using the derivation study alone, without any need for highly 
specialized knowledge or sophisticated statistics.
Keywords: clinical prediction rules, derivation, validation, meta-analysis, primary care
Background
What is new? 
A new, simplified method for computation of predicted number of outcomes in 
validation studies of clinical prediction rules (CPRs), for assessment of calibration 
performance in systematic reviews, is described. Our approach employs the frequency 
distribution pattern of the outcome in the derivation study (so called “derivation 
model”). Two CPRs (ABCD2 and CRB-65) are used as examples.
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The new approach is tested and further confirmed in 
terms of functionality and validity. We created dummy vari-
ables and applied univariate, CPR-based logistic regression 
(LR) model and its coefficients from the derivation study to 
a sample validation study thus producing virtually identical 
predicted values as obtained by our new method.
Predicted values from the validation studies are computed 
and pooled estimates of “predicted:observed” risk ratios 
(RRs) with their 95% confidence intervals (CIs) are obtained 
for the first time in a meta-analysis by using a “derivation 
model”. Beyond discrimination assessment, as part of the 
overall predictive performance, forest plots are used to 
illustrate how our new method contributes to the evaluation 
of calibration and how the latter may vary across different 
strata of risk or population sub-groups.
The implication is that, when predicted outcomes in 
validation studies are neither published nor accessible or 
sufficient or no individual patient data (IPD) are available, 
such predicted values can be easily obtained by our simpli-
fied method. Our new approach describes and justifies how 
this can be achieved by everyone, when using data from a 
derivation study alone, without any further requirements 
for highly specialized knowledge or sophisticated statistical 
software.
introduction to CPrs
CPRs are recognized as important tools for optimization of 
diagnostic processes, management, and treatment, especially 
in primary care. Known by various terms, “risk score”, 
“scorecard”, “algorithm”, and “guide”, CPRs are clinical 
techniques that quantify the contribution of a patient’s history, 
physical examination, and diagnostic tests to stratify patients 
and predict probability for a specific disorder or outcome 
(diagnosis, prognosis, referral, treatment). Although not 
designed to replace clinical knowledge or experience, CPRs 
offer additional, “smart” ways to assist doctors and providers 
in the diagnostic and prognostic processes.1
Phases of CPRs, derivation, and validation
Three obligatory phases exist in CPR development before 
it can be implemented in clinical practice: derivation, 
validation (narrow and broad), and clinical impact analysis 
(Figure A1.1 in the Supplementary materials).2,3 While the 
narrow validation can be either internal or external in the view 
of the derivation sample, the broad validation can be only an 
external one. Certain methodological standards are followed 
for CPR development and validation.4 At present, most CPRs 
are at the stage of initial development (derivation, mainly), 
fewer are validated and even less still were subject to impact 
analysis.
The derivation of CPRs is usually based on multivariable 
regression modeling by assessing a continuous outcome or 
the presence/absence of the target disorder and enabling the 
CPR development according to different sources of diag-
nostic or prognostic information.5 The resulting model may 
stratify patients into subgroups (low, intermediate or high 
risk) or compute predicted probabilities for the outcome. 
These probabilities serve to estimate, using a cut-off, the 
presence or absence of the outcome. CPRs can be based on 
and/or presented as equations with exact regression coeffi-
cients or as a more user-friendly, linear format like a simple 
score.6,7 Ideally, CPRs should be based on a small number 
of variables – in practice, few variables with strong effects 
usually explain most of the variance and account for most 
of the prognostic power. Although some loss of prognostic 
power is inevitable, the simplified rules often perform equally 
well compared to the more complex models. Once the CPR is 
derived, its overall performance (discrimination, calibration) 
is assessed. A reason for good performance might be that a 
simple rule, with a small number of highly predictive vari-
ables, is much less likely to be over-fitted (over-optimistically 
estimated) than complex models including also additional 
but weak predictors.8
The validation of a CPR can be done by using derivation 
study data (narrow internal validation), new data from the 
same source as the derivation study or other, similar popu-
lations (narrow external validation), but a true evaluation 
of predictive performance and generalizability (also called 
“transportability”) requires an evaluation in a heterogeneous 
population and another clinical setting/s (broad external 
validation).9,10 The proper validation implies that a fully 
specified, originally existing model (both the derivation study 
variables and coefficients) is used to compute the probability 
and obtain predicted outcomes and then compare the esti-
mates to the actual outcomes in the validation study.11
Unfortunately, the predictive performance often 
decreases when a model is tested in new patients, differ-
ent from those in the original model. Therefore, the CPR 
can be further adjusted or updated by combining the initial 
information (derivation study) and the new data (valida-
tion study).12–14
Predictive performance of a CPr
The predictive performance, or accuracy and reliability of a 
CPR in both derivation and validation studies should always 
be assessed in two aspects: discrimination and calibration.15 
Clinical Epidemiology 2015:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
269
A new approach to pooled analysis of calibration of CPRs in validation studies
Discrimination (accuracy) refers to the ability of CPR to 
correctly distinguish between presence and absence of 
the outcome, while calibration (reliability) is the agree-
ment between predicted probabilities of occurrence and 
observed proportions of the outcome. Discrimination of 
binary outcomes, for instance, is evaluated by concordance 
(c-statistic or receiver operating characteristic [ROC] curve). 
Good calibration refers to a good agreement between pre-
dicted probabilities and observed frequencies, eg, overall 
or across different strata by various CPR levels (ie, cut-off 
points). It is quantified by the comparison between, or ratio 
of the predicted to observed outcomes, usually verified by 
Hosmer-Lemeshow goodness-of-fit test, however, this test 
has low power to identify miscalibration in small samples.16 
Other tests of calibration are also applicable when IPD from 
validation studies do exist, however, without real IPD we 
used the Hosmer-Lemeshow test on “mimicked” IPD only 
as an illustration of some aspects of our methodological 
approach, eg, a (relative) change in the model calibration 
after an intercept adjustment. Another approach to assess 
calibration when IPD are not available is a direct compari-
son between the outcomes distribution (frequencies) in the 
original derivation sample and the outcome distribution in 
validation samples.
The latter technique is well illustrated by the association 
between the prognostic features of the CRB-65 rule (levels) 
and the risk distribution (%) for 30 day mortality among the 
derivation study and a single validation study (Figure 1).17 
There is a clearly increasing risk with the increasing CRB-
65 score (from 0 to 3). Although with a lower percentage 
of the outcome in the highest risk (4 points), the increasing 
trends are quite similar in both samples, in terms of both 
the score distribution and outcome distribution. While 
with good discrimination (area under the curve [AUC] 
ROC
 
= 0.79; 95% CI, 0.65–0.92), the calibration in terms of 
outcome frequency (%) at each of the score levels is not 
perfect. This one-to-one comparison indicates that CRB-
65 rule tends to under-predict mortality in the validation 
sample as compared to the derivation one (eg, CRB-65 
score of 2 points relates to mortality of 8.2% versus 11.8%, 
Figure 1).
Discrimination should be prioritized when judging a 
set of predictions or an overall CPR performance because 
if discrimination is poor, no calibration adjustment or other 
similar refinements of reliability can correct such weak 
discrimination. If discrimination is good, the CPR reliability 
(calibration) can be improved by adjustment, without com-
promising discrimination.18 Different techniques are known 
to adjust a CPR for improving its predictive performance 
during the validation (eg, recalibration, remodeling, etc).14 
For example, the Framingham score predicting 10-year 
cardiovascular disease (CVD) risk has been derived in the 
US population.19,20 Although with good discrimination and 
well calibrated to predict CVD events in populations from 
the USA, Australia, and New Zealand, it overestimates 
(over-predicts) the absolute risk in European cohorts and 
its direct implementation in the latter populations requires 
recalibration.20 An algorithm of CPR derivation and vali-
dation, including updating, is suggested (Figure A1.2 in 
Supplementary materials).
systematic reviews and  
meta-analyses of CPrs
The number of derived or validated CPRs has been increas-
ing recently.21 Several rules may predict the same outcome 
and, in parallel, a single rule may be validated in mul-
tiple populations and settings. Systematic reviews and, if 
appropriate, meta-analyses are the preferred tools to assess 
the prediction and level of evidence supporting the practical 
use of CPRs.22
Meta-analysis is used to summarize, evaluate, and 
present overall results of CPRs’ performance (pooled 
analysis) but most frequently in terms of discrimination23,24 
rather than calibration.25,26 Pooled, symmetrical summary 
ROC or hierarchical summary ROC curves27,28 are used to 
assess discrimination (with a “gold standard” for observed 
outcomes) at a particular CPR threshold. To evaluate cali-
bration, however, predicted number of outcomes should be 
published or possibly derivable from within each valida-
tion study. A good example of such calibration assessment 
with published or accessible predicted values (expressed as 
“predicted to observed ratio”) was reported in 200625 for 
the Framingham Anderson and Wilson scores for 10-year 
Original data set by Lim
et al,34 n (%)
(N=932)
CRB-65
score Total
0a
4a
1
2
3
212 (22.7)
14 (1.5)
344 (36.9)
251 (26.9)
111 (11.9)
2 (0.9)
3 (21.4)
18 (5.2)
30 (11.8)
36 (32.4)
0
0
230 (73.2)
61 (19.4)
23 (7.3)
0
0
2 (0.9)
5 (8.2)
4 (17.4)
Mortality MortalityTotal
Original data by Bont et al,17
n (%)
(N=314)
Figure 1 An example of the comparison of prognostic features of CRB-65 rule in 
the view of predicting 30 day mortality from pneumonia between the derivation and 
a validation study.
Notes: aAll patients in the present study were 65 years or older. Therefore, there 
were no patients with a CRB-65 score of 0. Also, no patients had a score of 4 or 
higher. Reproduced with the written permission from Bont et al.17
Abbreviation: CrB-65, confusion, respiratory rate 30/minute or higher, low blood 
pressure (90 mmhg systolic or 60 mmhg diastolic), age 65 years or older.
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CVD risk (Figure A1.3). Interestingly, when all validation 
studies are ordered by the increasing observed CVD risk 
(top to bottom), a clear pattern of changing calibration, 
from over-prediction to under-prediction (from right to left) 
emerges.25
However, such calibration assessment cannot be done 
if no predicted values are published or accessible from 
validation studies. In principle, one possible approach 
in such situations is to estimate outcomes by using, for 
instance, the CPR as a predictor in a validation study. 
The predicted probabilities and the number of predicted 
outcomes can be computed by univariable (only CPR as 
predictor) or multivariable models (including also other 
covariates). Such computation of individual probabilities 
is not always an immediate procedure – it often requires 
high-level statistical knowledge and sophisticated software 
or, at least, that the model equations and coefficients are 
published or accessible. If the latter are available, then even 
simple calculations with the coefficients is sufficient to pro-
duce the predicted probabilities. The main problem, when 
neither predicted values are published nor enough data are 
available (including IPD), is that none of above techniques 
can be used. Therefore, another, new approach is needed 
to predict probabilities and outcomes for the assessment of 
calibration levels of CPRs in systematic reviews.
The aim of our present study was to introduce and describe 
a new, simple methodological approach which, using infor-
mation from derivation study (eg, referred to as “derivation 
model”) allowed a calculation of the predicted values in 
validation studies. It is mainly applicable when individual 
participant, or patient data (database, IPD) are not available 
from all validation studies. The approach implies exploration 
of “predicted:observed” ratios in the usual meta-analytic way 
to assess CPR calibration (on a forest plot) and is illustrated 
by two rules: ABCD2 and CRB-65.29,30–31 The first objective 
was to employ the frequency distribution (%) of the observed 
outcomes in the derivation study and to apply it to predict 
the outcomes in a sample validation study. As a second 
objective, we aimed at confirming the functionality of the 
approach by using LR model coefficients from the derivation 
study to the validation study data. As a third objective, we 
aimed at assessing the role of different outcome incidences 
(a priori probabilities) from different validation studies, 
adjusting the original model intercept13 and examining the 
CPR performance and pooled estimates from the meta-
analysis. Only the main ABCD2 rule results are reported in 
the main text (the remaining, including those on the CRB-65 
rule, are shown in the Supplementary materials only).
Methods
To develop and illustrate our new approach, we utilized data 
from ABCD2 rule to predict stroke in transient ischemic attack 
patients and CRB-65 rule to predict mortality in pneumonia 
patients. With the purpose of simulating IPD sets, we selected 
only validation studies with available numbers of patients and 
outcome distribution (%) at each scoring point. Also, both CPRs 
were derived from LR models without complex interaction 
terms,33,34 ie, only with single predictors (variables). It means 
that the numerical “weights” of the components (predictors) 
in the CPRs were based only on fitted LR model coefficients, 
therefore, the patients had the same ranking in the models as 
in the CPRs (both related to predicted probability).
The outcome in ABCD2 rule was “stroke at 7 days” 
while that for the CRB-65 rule was “30 day in-hospital 
mortality”.30,31 The results, in terms of calibration, are shown as 
“predicted:observed” RRs with 95% CIs. The RR 1 indicates 
under-prediction (under-estimation) of stroke or death (observed 
number is greater than predicted number); RR .1 indicates over-
prediction (over-estimation) of the outcome (observed number 
is less than the predicted number) while RR =1 indicates perfect 
calibration between observed and predicted values. Pooled esti-
mates were calculated by fixed and random effect models while 
heterogeneity across studies was quantified by the I2-index.
New, simplified approach to derive 
predicted values in a validation study
The outcome distributions in derivation33 and validation 
studies of ABCD2 rule, overall and according to three strata 
of stroke risk (scores 0–3, 4–5, and 6–7), are presented in 
Figure A1.4 and Table A1.1 (Supplementary materials). 
The distribution in the original derivation study (column 3, 
Table 1) was used as a “predictive model” to which a valida-
tion study was to be related. To calculate the predicted number 
of strokes in the validation cohort,33 the proportionate risk 
estimate from the derivation cohort was applied according 
to each separate stratum of risk: low (stroke risk =1.35%), 
intermediate (6.51%), and high (11.30%) (column 5, Table 1). 
The number of strokes across the strata of risk in the valida-
tion cohort as predicted by ABCD2 rule “derivation model” 
(column 6, Table 1) was then compared to the observed strokes 
(column 7, Table 1). It should be noted that our new simplified 
approach is applicable not only to the whole sample (range) 
of such CPR score, overall, but if sufficient data exist (as in 
the example in Figure 1) – also to each one of the individual 
levels of the scoring (point) system of such CPR.
Respectively, outcome distributions in derivation and 
validation studies of the CRB-65 rule are presented in 
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Figure A2.1 and Table A2.1A (Supplementary materials) 
while the results from the application of the new approach 
to compute predicted deaths in sample validation study35 are 
presented in Tables A2.1B-C (Supplementary materials).
Predicted values from the coefficients  
of the regression model
The next step was to confirm our findings in terms of feasibility, 
functionality, and agreement with other existing approaches 
or models (ie, to test construct or convergent validity) by 
using predicted outcomes by ABCD2 rule.33 We constructed a 
univariate saturated LR prediction model and its coefficients 
from the derivation study data. Since we did not have the 
original IPD, the only technique was to assume a dichotomous 
outcome (binary variable for stroke at 7 days: present = Yes =1 
and absent = No =0) and include the ABCD2 rule as a single, 
independent predictor. The ABCD2 score (range 0–7) is not a 
true continuous variable and thus we avoided an assumption 
of linearity by including ABCD2 rule in the model as a set 
of discrete independent categorical variables, with score in 
the low-risk ABCD2 stratum (0–3) as a reference category.36 
We converted the ABCD2 variable into two dummy, related 
dichotomous variables (one related to intermediate risk, 
4–5 score and the other to high risk, 6–7 score) and included 
them into multiple regression model as two single predic-
tors from the derivation study (Figure 2: panel A). The same 
technique for dummy variables was also successfully applied 
to the risk-stratified data from ABCD2 validation study33 
(Figure 2: panel B) to use these data to apply the “derivation 
study” model and its coefficients (see below).
Table 1 Observed and predicted number of strokes in the validation sample using the distribution patterns of strokes in the derivation 
sample as a predictive model*
Stroke risk by ABCD2  
rule (score levels)
Derivation study Validation study
Patients  
(N)
Observed strokes 
n (%)
Patients  
(N)
Predicted  
incidence (%)**
Predicted  
number (n)
Observed  
number (n)***
Low risk (0–3 points) 520 7 (1.35) 426 1.35 5.8 (≈6) 2
Intermediate risk (4–5 points) 921 60 (6.51) 397 6.51 25.8 (≈26) 17
High risk (6–7 points) 469 53 (11.30) 139 11.30 15.7 (≈16) 10
Notes: *Validation sample (California Clinic [n=962] cohort, Johnston et al 2007),33 derivation sample (California ED [n=1,707] and Oxford population-based [n=209] 
cohorts, Johnston et al, 2007)33; **stroke incidence in each risk stratum of the validation study (data from California, USA) according to the distribution patterns of stroke in 
the original, derivation study (as used as a predictive model); ***actual number of strokes as reported in each stratum of risk.
Abbreviation: ED, emergency department.
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Figure 2 Creation of dummy variables for the ABCD2 rule to perform logistic regression analysis at individual level.
Notes: “…” indicates an interruption of the columns to prevent listing all simulated data (an appropriate example is given for each risk stratum, ie, for each point in the 
aBCD2 score range from 0 to 7 points). 
Abbreviation: inT, intermediate.
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The equation of the prediction model in the derivation 
study of the ABCD2 rule is:
 
Log
risk of  stroke
1  risk of  stroke
linear predictor 
−




= Y
X XINT INT HIGH HIGH
 
 = α +β β+  (1)
where a is the intercept and β
INT
 and β
HIGH
 are the regression 
coefficients of the dummy variables “intermediate risk” and 
“high risk”, respectively. The predicted probability of stroke 
for each simulated individual patient can be calculated as:
 P =
+
e
e
Y
Y( )1
 
(2)
We obtained the regression equation with the predictors and 
their coefficients as:
 Y 4.29 X XINT HIGH=− + +1 63 2 23. .  (3)
For instance, if a patient ABCD2 score in the derivation study 
has been computed as either 0, 1, 2 or 3 points (low-risk, score 
0–3), this patient would get Y=−4.29 resulting in a probability 
of 1.35% (95% CI 0.6–2.8) to have a stroke in 7 days. A patient 
ABCD2 score of 4 or 5 points would get Y=−4.29+1.63=−2.66 
resulting in 6.51% (95% CI 5.1–8.3). Similarly, a patient 
ABCD2 score of 6 or 7 will get Y=−4.29+2.23=−2.06 result-
ing in 11.3% (95% CI 8.7–14.5).
As mentioned, we used above “derivation study” 
 coefficients to predict probabilities and number of strokes in 
the validation study (ie, using dummy variables as in Figure 2: 
panel B). The linear estimate Y
VAL
 in the validation study33 
(column 6, Table 2) was calculated as:
 
Y X XVAL DER= + +α β βINT,DER INT,VAL HIGH,DER HIGH,VAL (4)
where a
DER 
(−4.29) is the intercept and β
INT,DER
 (1.63) and 
β
HIGH,DER
 (2.23) are the coefficients from the derivation study 
(see equation (3) above). The X
INT,VAL
 and X
HIGH,VAL
 are the 
ABCD2 values as dummy variables data (“intermediate risk” 
and “high risk” strata) from the validation study (Figure 2: 
panel B). In this way, the predicted probability of stroke at 
individual level P (last column, Table 2), ie, for each simu-
lated patient, was computed as:
Table 2 individual patient probability P for stroke in the validation sample* as computed by the logistic regression equation (intercept 
and coefficients) from the derivation study
Patient Stroke ABCD2 Dummy  
intermediate (XINT)
Dummy  
high (XHIGH)
YVAL P**
1 0 0 0 0 −4.29 0.0135
… … … … … … …
15 0 0 0 0 −4.29 0.0135
16 0 1 0 0 −4.29 0.0135
… … … … … … …
80 0 1 0 0 −4.29 0.0135
81 1 2 0 0 −4.29 0.0135
… … … … … … …
228 0 2 0 0 −4.29 0.0135
229 1 3 0 0 −4.29 0.0135
… … … … … … …
426 0 3 0 0 −4.29 0.0135
427 1 4 1 0 −2.66 0.0651
… … … … … … …
656 0 4 1 0 −2.66 0.0651
657 1 5 1 0 −2.66 0.0651
… … … … …
823 0 5 1 0 −2.66 0.0651
824 1 6 0 1 −2.06 0.113
… … … … … … …
936 0 6 0 1 −2.06 0.113
937 1 7 0 1 −2.06 0.113
… … … … … … …
962 0 7 0 1 −2.06 0.113
Notes: *Validation sample (California clinic data, Johnston et al, 2007)33; **individual level probability (last column) in each of the risk strata of the ABCD2 score is later used 
to compute the predicted number of strokes. “…” indicates an interruption of the columns to prevent listing all simulated data (an appropriate example is given for each risk 
stratum, ie, for each point in the ABCD2 score range from 0 to 7 points).
Abbreviations: inT, intermediate, Val, validation.
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P =
+( )
e
e
Y
Y
VAL
VAL1
.  (5)
Then we added up the individual probabilities P in 
Table 2 (last column) to predict the number of strokes within 
each separate stratum of risk: low-risk 0–3 (expected =5.7), 
intermediate risk 4–5 (25.9) and high risk 6–7 (15.7). When 
rounded, these expected values give 6, 26 and 16 predicted 
strokes (last column, Table 3).
The same algorithm, confirming the validity of our new 
approach to predict 30 day mortality by CRB-65 rule, is pre-
sented in the Supplementary materials (Tables A2.2A-D).
Meta-analysis, performance  
measures, and adjustment of intercept 
(updating) in validation studies
The predicted number of strokes and predicted:observed 
RRs in validation studies of ABCD2 rule are computed 
and subjected to meta-analysis with fixed and random-
effects models. The results are presented as pooled 
estimates of RRs, together with measures of discrimina-
tion, calibration, and heterogeneity (Tables 4 and 5 and 
forest plots in Figures 3–5). Updating the intercept of 
original LR model corrects the calibration “at large”, 
that is, it “adjusts” the mean predicted probability for 
the latter to become equal to frequency of the observed 
outcome. Only the intercept of the original model (deri-
vation study) is adjusted. This can be achieved by fitting 
LR model in validation study with the intercept a as 
the only free parameter and the linear estimate Y
VAL
 as 
an offset variable (ie, the slope is fixed at unity).14 The 
following equation illustrates the adjustment procedure:
 
Log
risk of  stroke
1 risk of  stroke−




= linear predictor YCAL
CAL VALY= +α .
 
(6)
Then, the predicted probability of stroke for each separate 
validation study of the ABCD2 rule was calculated with the 
usual equation:
 P
e
e
Y
Y
CAL
CAL
=
+



1
. (7)
Once the probabilities with the adjusted intercepts are 
obtained for each simulated patient, the adjusted results 
from the meta-analysis with fixed effects can be presented 
for comparison purposes, in the same way, with the measures 
of performance and heterogeneity (Tables 4 and 5 and forest 
plots in Figures 3–5: panel C) as described in more detail in 
the section “Results”.
The same computations from a meta-analysis (without 
and with adjustment) on the estimates of 30 day mortality 
by CRB-65 rule in validation studies are presented only in 
Supplementary materials (forest plots in Figures A2.3.1, 
A2.3.2, and A2.3.3, Table A2.4 and Table A2.5).
Results
The main result of our current methodological work was 
the introduction of a new, simplified approach to compute 
predicted values and derive “predicted:observed” ratio of out-
comes and assess calibration in validation studies of CPRs. 
This was achieved by using information from the derivation 
study (eg, referred to as “derivation model”) (Table 1).
As the main example we used the ABCD2 rule to predict 
the number of strokes and the approach was confirmed in 
terms of construct and congruent validities of predicted esti-
mates. Using simulated IPD with dummy variables, we fitted 
a CPR-based LR model with its coefficients from the deriva-
tion study to data from sample validation study (Figure 2 and 
Table 2). We obtained the same number of predicted outcomes 
(Table 3) as computed by our new, simplified approach 
(Table 4). The identical results obtained by the new simplified 
approach (using a linear scale distribution from derivation 
sample onto the validation sample, ie, as from 0 to 7 points) 
and by the non-linear, more complex logistic relationship 
with the dummy variables to get individual predicted prob-
abilities, is confirmation of its validity. Our current analysis 
included derivation and validation studies that ranged in size 
from 136 to 1,054 patients (ABCD2 rule) and from 137 to 
1,100 patients (CRB-65 rule) (Supplementary materials: 
Figure A1.4, Table A1.1, Figure A 2.1, Table A 2.1A). Addi-
tional information on the validation studies and further details 
were reported earlier.30,31
To further illustrate usefulness of our new approach 
in assessing the CPR predictive performance in terms 
of calibration, we obtained predicted outcomes and 
Table 3 Observed and predicted numbers of strokes in the 
vali dation study* as computed by the use of the individual level 
proba bilities P from the logistic regression equation with dummy 
variables
Risk for stroke by the  
ABCD2 rule (score levels)
Observed 
strokes (n)
Patients 
(N)
Predicted 
strokes (n)**
Low risk (0–3 points) 2 426 5.7 (≈6)
Intermediate risk (4–5 points) 17 397 25.9 (≈26)
High risk (6–7 points) 10 139 15.7 (≈16)
Notes: *Data from the validation study (California Clinic [n=962] cohort, Johnston 
et al 2007)33; **the probability in each risk stratum of the ABCD2 rule is added up to 
obtain the number of predicted stokes.
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“predicted:observed” ratios in the validation studies and sub-
jected them to formal meta-analysis. We thoroughly assessed 
the discrimination and calibration in each included validation 
study of the ABCD2 rule (Table 4) and we also illustrated with 
forest plots the summary estimates of calibration (pooled RRs 
with their 95% CIs), together with levels of heterogeneity 
(Figures 3–5). Notably, beyond overall good discrimination 
across all included studies (c-statistics 0.608–0.819), calibra-
tion levels in some of the studies were low, with a tendency 
of under-estimation (under-prediction). The latter tendency 
can be more clearly observed when illustrated by the level 
of assumed risk of stroke as defined by different levels of 
ABCD2 rule score (low: 0–3, intermediate: 4–5 and high: 
6–7 points, Table 5).
The slight under-prediction (RR from 0.73 to 0.91, 95% 
CIs include 1.00), possibly due to increased heterogene-
ity (18.8%–66.1%) in some of the risk strata, could be 
further corrected by adjustment of the original intercept 
to take into account the different incidence rates (a priori 
probabilities). In this way our new, simplified approach was 
able to identify low calibration levels (eg, under- prediction) 
which could be further refined. While discrimination does 
not improve further by such intercept adjustment (Table 4), 
better calibration coefficients (Table 4, last column) and 
improved pooled estimates (RR 0.90–1.06, Table 5), with 
narrower 95% CIs and zero heterogeneity were achieved.
Discussion
CPRs are a valuable tool in supporting clinicians, especially 
in primary care, in making evidence-based decisions when 
relying on clinical history, physical examination, and basic 
investigations. We employ a pragmatic approach to introduce 
new, simplified methodology of computing the predicted 
number and “predicted:observed” ratio of outcomes in valida-
tion studies of CPRs for assessing calibration in systematic 
reviews.
Main results
In the context of previous research on CPR validation where 
preference was always given to discrimination rather than 
calibration, our current results indicate the usefulness, fea-
sibility, and validity (construct and congruent) of our new 
approach for calibration assessment. Producing predicted 
outcomes and pooled estimates of calibration, based on the 
frequency distribution pattern (%) of the outcome in the CPR 
derivation study, is denoted as a “derivation model”.
Table 4 Performance of the ABCD2 rule in validation studies
Study ID Discrimination (c-statistic) Calibration (H-L P-value*)
No adjustment 
(original CPR)
Adjustment  
of intercept
No adjustment 
(original CPR)
Adjustment 
of intercept
asimos et al (2007)41 0.677 0.677 0.002 0.593
ay et al (2009)42 0.650 0.650 0.791 0.922
Johnston et al (2007), California clinic43 0.722 0.722 0.045 0.873
Johnston et al (2007), California ED43 0.623 0.623 0.099 0.100
Cucchiara et al (2009)44 0.673 0.673 0.253 0.421
Fothergill et al (2009)45 0.608 0.608 0.001 0.527
Ong et al (2010)46 0.649 0.649 0.001 0.298
Rothwell et al (2007), Oxford clinic47 0.763 0.763 0.476 0.713
Rothwell et al (2007), Oxford population47 0.819 0.819 0.001 0.004
song et al (2009)48 0.741 0.741 0.001 0.900
Tsivgoulis et al (2007)49 0.720 0.720 0.213 0.882
Tsivgoulis et al (2010)50 0.724 0.724 0.174 0.875
Note: *H-L, Hosmer-Lemeshow “goodness-of-fit” P-value (a non-significant P-value means good fit – the higher the P-value, the better the fit).
Abbreviation: CPr, clinical prediction rule; ED, emergency department.
Table 5 Meta-analysis with pooled RRs and 95% CIs from the validation studies of the ABCD2 rule – comparison between our new 
approach (original CPR) and an updated logistic regression model
Stroke risk by ABCD2  
rule (score levels)
No adjustment (original CPR) Adjustment of intercept
I2 Fixed effects Random effects I2 Fixed effects
Low risk (0–3 points) 18.3% 0.73 (0.45–1.20) 0.78 (0.41–1.48) 0.0% 0.90 (0.57–1.41)
Intermediate risk (4–5 points) 66.1% 0.91 (0.75–1.11) 0.88 (0.61–1.28) 0.0% 1.06 (0.88–1.28)
High risk (6–7 points) 52.6% 0.85 (0.68–1.06) 0.79 (0.55–1.15) 0.0% 0.95 (0.77–1.17)
Abbreviations: RRs, risk ratios; CIs, confidence intervals; I2, coefficient of heterogeneity; CPR, clinical prediction rule.
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The clinical need for assessing calibration of CPR, and 
possibly improving it, has been clearly shown by discrepancies 
in the application of the Framingham score for 10-year CVD 
risk in European populations.19,20 While being calibrated in 
populations from the USA, Australia, and New Zealand, it 
overestimates (over-predicts) the absolute risk in Europe 
and requires further recalibration.20 A systematic review of 
validation studies even indicated that an interesting, newly 
detected dynamic pattern from over-prediction to under-
prediction emerges with the increase of the observed risk.25 
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Figure 3 Forest plots of the ABCD2 rule (low risk).
Notes: (A) No adjustment (the original prediction rule) – fixed effects; (B) no adjustment (the original prediction rule) – random effects; (C) adjustment of the intercept – 
fixed effects.
Abbreviations: RR, risk ratio; CI, confidence interval.
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However, the above conjectures about calibration could never 
have been made if the predicted outcomes had not existed in 
CPR validation studies or were not accessible.
Our new approach is very useful in producing predicted 
outcomes by CPRs when needed for: i) assessment of calibra-
tion levels and/or subsequent inclusion of validation studies 
in meta-analysis; ii) signaling miscalibration and measuring 
improvements of calibration by updating (eg, adjustment of the 
intercept of derivation model); iii) comparison with predicted 
values as computed by other models and techniques (eg, confir-
mation of construct validity in ABCD2 and CRB-65 rules); and 
iv) further testing and, if necessary, refinement and improvement 
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Figure 4 Forest plots of the ABCD2 rule (intermediate risk).
Notes: (A) No adjustment (the original prediction rule) – fixed effects; (B) no adjustment (the original prediction rule) – random effects; (C) adjustment of the intercept – 
fixed effects.
Abbreviations: RR, risk ratio; CI, confidence interval.
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in terms of transportability with assessment and comparison 
of calibration between different but similar CPRs for the same 
outcome in same or different validation populations. To note, 
the same approach is also applicable to systematic reviews of 
validation studies for prediction of long-term risk of stroke 
after transient ischaemic attack.32
limitations
One limitation of our approach is that the pooled analysis 
does not consider the specific frequency of the outcomes in 
each separate study; however, such assessment of calibra-
tion may be seen also as a new way for preliminary analysis 
to quantify, beyond the discrimination, the level of CPR 
Note: Weights are from random effects analysis
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Figure 5 Forest plots of aBCD2 (high risk).
Notes: (A) No adjustment (the original prediction rule) – fixed effects; (B) no adjustment (the original prediction rule) – random effects; (C) adjustment of the intercept – 
fixed effects.
Abbreviations: RR, risk ratio; CI, confidence interval.
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calibration and to decide whether or not a rule should be 
recalibrated (eg, intercept adjustment). This is especially 
useful when IPD from validation studies are neither available 
nor easily accessible. Second, the CPR calibration might be 
influenced by the incidence in a separate validation study. 
However, before any further advice is given for recalibration, 
the predicted values and estimated calibration (ie, predicted 
versus observed values with their 95% CIs) can be adjusted 
to or computed for a range of different incidences. The lat-
ter approach was successfully applied in meta-analysis of 
validation studies of Centor score.37 For instance, the post-
test probabilities of group A beta-hemolytic streptococcal 
pharyngitis were computed in a tabular form for a range of 
pre-test (prevalence) probabilities by the Poses’s method38 
using the likelihood ratio formulation of the Bayes’ theorem 
to adjust for different prevalence rates. Last but not least, 
in the current approach we used each of the tested CPRs as 
single (solely) predictor of the outcome, however, these rules 
had components (signs or symptoms) with more or less the 
same weight (1 or 2 points each) and the underlying models 
had no complex interaction terms.
Clinical relevance and future research
Our results have immediate clinical application in the view 
of summarizing best available evidence (systematic review) 
from validation studies of CPRs. They allow subjecting 
each study’s data to formal meta-analysis to produce pooled 
estimates not only of discrimination, but also of calibration 
by applying previously published models (derivation study) 
to a new, validation population. Unfortunately, currently 
only about half of the derived CPRs in primary care have 
been validated and only a few have been assessed for clini-
cal impact.39 As another recent study has also emphasized,40 
the use of appropriately validated and tested CPRs is one of 
the best ways of implementing evidence-based medicine for 
diagnosis and prognosis in the clinical practice. In this sense 
we suggest that all systematic reviews with meta-analysis 
of CPR, as well as all validation studies, always report both 
discrimination and calibration analyses. Finally, the poten-
tial gain in predictive accuracy and generalizability of CPR 
developed on combined datasets, with IPD from various 
studies on the same outcome (ie, IPD meta-analysis) is an 
area of recently intensified research that warrants further 
investigations.
Conclusion
In summary, our current study has presented a new, simplified 
method for computation of predicted number of outcomes 
in validation studies of CPRs for assessment of calibration 
performance. This method is based on the frequency distri-
bution pattern of derivation study outcomes. We illustrated 
the development and application of this new approach 
(ie, “derivation model”) on two clinically relevant and widely 
used CPRs (ABCD2 and CRB-65).
Our new approach was tested and further confirmed 
in terms of functionality and validity by original, univari-
ate, CPR-based LR modeling (ie, with dummy variables) 
using derivation study data. The application of coefficients 
from this regression model to a sample validation study 
produced virtually identical predicted values of stroke 
across the three risk strata of ABCD2 score (low, 0–3; 
intermediate, 4–5; high, 6–7 points). Then, by using our new 
method, we successfully computed predicted values in all 
included validation studies and obtained pooled estimates 
of “predicted:observed” RRs with their 95% CIs. Given the 
good discrimination performance, the slight under-prediction 
of strokes was further improved by intercept adjustment to 
show how different incidences of the outcome in each vali-
dation study can be considered and thus, providing further 
evidence on the usefulness of our approach. Once such 
miscalibration in a meta-analysis is signaled by our new 
approach, further refinements of the original intercept are 
possible by more sophisticated modeling exercises. Similarly, 
the successful application of our new method was also illus-
trated on the CRB-65 rule (Supplementary materials).
When predicted outcomes are neither published nor suf-
ficient as from within validation studies of CPRs, or no IPD 
are available, our simplified approach illustrates, for the first 
time, how predicted outcomes can be obtained by everyone, 
when using only derivation study, without any further require-
ments for highly-specialized knowledge or sophisticated 
analyses. Last but not least, our new results have immediate 
clinical implication in contributing to exploration of the 
best available evidence from validation studies of CPRs (ie, 
systematic reviews). They allow not only subjecting the data 
to meta-analysis for computation of discrimination but also 
to produce pooled estimates for evaluation of calibration in 
new, validation populations.
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